Last 12 months
Inside the activity.
0 purchase rows · 42 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 10 |
| Jan 2026 | 0 | 17 |
| Feb 2026 | 0 | 1 |
| Mar 2026 | 0 | 13 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 03, 2024 Filed Jan 5, 2024 22:00 UTC |
Lizzul Paul F.Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 42,220 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001052 · doc4.xml · derivative · entry 2 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 42,220 Underlying: Common Stock · 42,220 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 22:00 UTC |
Lizzul Paul F.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 115,540 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001209191-24-001052 · doc4.xml · derivative · entry 1 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 115,540 Underlying: Common Stock · 115,540 shares Expires 2034-01-02 F1 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 3, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:52 UTC |
Faga DanielDirector · CEO
|
GrantRestricted Stock Unit · Derivative | 138,710 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001044 · doc4.xml · derivative · entry 2 Faga Daniel · CIK 0001673528 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 138,710 Underlying: Common Stock · 138,710 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:52 UTC |
Faga DanielDirector · CEO
|
GrantStock Option (right to buy) · Derivative | 379,620 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001209191-24-001044 · doc4.xml · derivative · entry 1 Faga Daniel · CIK 0001673528 · Director · CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 379,620 Underlying: Common Stock · 379,620 shares Expires 2034-01-02 F1 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 3, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:58 UTC |
Schmid John P.Director
|
GrantRestricted Stock Unit · Derivative | 6,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001050 · doc4.xml · derivative · entry 2 Schmid John P. · CIK 0001478916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,030 Underlying: Common Stock · 6,030 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:58 UTC |
Schmid John P.Director
|
GrantStock Option (right to buy) · Derivative | 16,510 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001209191-24-001050 · doc4.xml · derivative · entry 1 Schmid John P. · CIK 0001478916 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,510 Underlying: Common Stock · 16,510 shares Expires 2034-01-02 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 3, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:57 UTC |
Orwin John ADirector
|
GrantRestricted Stock Unit · Derivative | 6,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001049 · doc4.xml · derivative · entry 2 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,030 Underlying: Common Stock · 6,030 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:57 UTC |
Orwin John ADirector
|
GrantStock Option (right to buy) · Derivative | 16,510 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001209191-24-001049 · doc4.xml · derivative · entry 1 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,510 Underlying: Common Stock · 16,510 shares Expires 2034-01-02 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 3, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 16:55 UTC |
LOUMEAU ERIC JChief Legal Officer
|
GrantRestricted Stock Unit · Derivative | 29,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001047 · doc4.xml · derivative · entry 2 LOUMEAU ERIC J · CIK 0001239648 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,150 Underlying: Common Stock · 29,150 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 16:55 UTC |
LOUMEAU ERIC JChief Legal Officer
|
GrantStock Option (right to buy) · Derivative | 79,780 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001209191-24-001047 · doc4.xml · derivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,780 Underlying: Common Stock · 79,780 shares Expires 2034-01-02 F1 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 3, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:53 UTC |
FENTON DENNIS MDirector
|
GrantRestricted Stock Unit · Derivative | 6,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001045 · doc4.xml · derivative · entry 2 FENTON DENNIS M · CIK 0001184627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,030 Underlying: Common Stock · 6,030 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:53 UTC |
FENTON DENNIS MDirector
|
GrantStock Option (right to buy) · Derivative | 16,510 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001209191-24-001045 · doc4.xml · derivative · entry 1 FENTON DENNIS M · CIK 0001184627 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,510 Underlying: Common Stock · 16,510 shares Expires 2034-01-02 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 3, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:56 UTC |
RENTON HOLLINGSDirector
|
GrantRestricted Stock Unit · Derivative | 6,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001048 · doc4.xml · derivative · entry 2 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,030 Underlying: Common Stock · 6,030 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:56 UTC |
RENTON HOLLINGSDirector
|
GrantStock Option (right to buy) · Derivative | 16,510 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001209191-24-001048 · doc4.xml · derivative · entry 1 RENTON HOLLINGS · CIK 0001187333 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,510 Underlying: Common Stock · 16,510 shares Expires 2034-01-02 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 3, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:54 UTC |
MULROY DENNISChief Financial Officer
|
GrantRestricted Stock Unit · Derivative | 33,170 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001046 · doc4.xml · derivative · entry 2 MULROY DENNIS · CIK 0001276840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,170 Underlying: Common Stock · 33,170 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 3, 2025 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:54 UTC |
MULROY DENNISChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 90,780 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001209191-24-001046 · doc4.xml · derivative · entry 1 MULROY DENNIS · CIK 0001276840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,780 Underlying: Common Stock · 90,780 shares Expires 2034-01-02 F1 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 3, 2025, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 22:01 UTC |
Jain RitaDirector
|
GrantRestricted Stock Unit · Derivative | 6,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001053 · doc4.xml · derivative · entry 2 Jain Rita · CIK 0001707797 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,030 Underlying: Common Stock · 6,030 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 22:01 UTC |
Jain RitaDirector
|
GrantStock Option (right to buy) · Derivative | 16,510 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001209191-24-001053 · doc4.xml · derivative · entry 1 Jain Rita · CIK 0001707797 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,510 Underlying: Common Stock · 16,510 shares Expires 2034-01-02 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 3, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:59 UTC |
Marquet MagdaDirector
|
GrantRestricted Stock Unit · Derivative | 6,030 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-24-001051 · doc4.xml · derivative · entry 2 Marquet Magda · CIK 0001631486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,030 Underlying: Common Stock · 6,030 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2025 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 21:59 UTC |
Marquet MagdaDirector
|
GrantStock Option (right to buy) · Derivative | 16,510 | $0.00 Strike: $21.19 | $0.00 |
DisclosureSEC source: 0001209191-24-001051 · doc4.xml · derivative · entry 1 Marquet Magda · CIK 0001631486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,510 Underlying: Common Stock · 16,510 shares Expires 2034-01-02 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on Februray 3, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| November 22, 2023 Filed Nov 27, 2023 16:03 UTC |
LOUMEAU ERIC JChief Legal Officer
|
SaleCommon Stock | 882 | $14.19 | $12,515.58 |
DisclosureSEC source: 0001209191-23-056638 · doc4.xml · nonDerivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person dated September 29, 2022, as amended February 21, 2023. F2 · shares: The shares sold represent 882 shares purchased pursuant to the Company's ESPP at 85% of the lesser of the closing price of the Issuer's Common Stock on November 16, 2022 and the closing price of May 15, 2023. Read SEC document |
| September 18, 2023 Filed Sep 18, 2023 18:13 UTC |
LOUMEAU ERIC JChief Legal Officer
|
SaleCommon Stock | 3,895 | $19.32 | $75,232.31 |
DisclosureSEC source: 0001209191-23-049809 · doc4.xml · nonDerivative · entry 3 LOUMEAU ERIC J · CIK 0001239648 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 882 F4 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.135 to $19.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 18, 2023 Filed Sep 18, 2023 22:12 UTC |
MULROY DENNISChief Financial Officer
|
SaleCommon Stock | 3,895 | $19.32 | $75,236.60 |
DisclosureSEC source: 0001209191-23-049808 · doc4.xml · nonDerivative · entry 3 MULROY DENNIS · CIK 0001276840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 964 F3 · kind: The transactions reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.145 to $19.60, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth herein. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:11 UTC |
Orwin John ADirector
|
GrantRestricted Stock Unit · Derivative | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-049806 · doc4.xml · derivative · entry 4 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,900 Underlying: Common Stock · 3,900 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: The RSUs shall vest as to 1/3 of the total shares on September 15, 2024, and thereafter vests as to 1/3 of the total RSUs on September 15, 2025; and as to 1/3 of the total RSUs on September 15, 2026, subject to the provision of services to the Company on each vesting date. F5 · derivative.expiration_date: The RSUs shall vest as to 1/3 of the total shares on September 15, 2024, and thereafter vests as to 1/3 of the total RSUs on September 15, 2025; and as to 1/3 of the total RSUs on September 15, 2026, subject to the provision of services to the Company on each vesting date. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:11 UTC |
Orwin John ADirector
|
GrantRestricted Stock Unit · Derivative | 2,035 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-049806 · doc4.xml · derivative · entry 3 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,035 Underlying: Common Stock · 2,035 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F4 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:11 UTC |
Orwin John ADirector
|
GrantStock Option (right to buy) · Derivative | 10,600 | $0.00 Strike: $19.50 | $0.00 |
DisclosureSEC source: 0001209191-23-049806 · doc4.xml · derivative · entry 2 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,600 Underlying: Common Stock · 10,600 shares Expires 2033-09-14 F2 · derivative.exercise_date: The stock option vests as of 1/36 of the total shares monthly beginning on October 15, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| September 15, 2023 Filed Sep 18, 2023 22:11 UTC |
Orwin John ADirector
|
GrantStock Option (right to buy) · Derivative | 3,311 | $0.00 Strike: $19.50 | $0.00 |
DisclosureSEC source: 0001209191-23-049806 · doc4.xml · derivative · entry 1 Orwin John A · CIK 0001477384 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,311 Underlying: Common Stock · 3,311 shares Expires 2033-09-14 F1 · derivative.exercise_date: The stock option vests as of 1/4 of the total shares monthly beginning on October 6, 2023 and each month thereafter until fully vested on January 6, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:14 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-049810 · doc4.xml · derivative · entry 3 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: 50% of the total restricted stock units vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F4 · derivative.expiration_date: 50% of the total restricted stock units vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:14 UTC |
Lizzul Paul F.Chief Medical Officer
|
SaleCommon Stock | 2,105 | $19.48 | $41,005.40 |
DisclosureSEC source: 0001209191-23-049810 · doc4.xml · nonDerivative · entry 2 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,527 F3 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:14 UTC |
Lizzul Paul F.Chief Medical Officer
|
Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-049810 · doc4.xml · nonDerivative · entry 1 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,632 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · balance_after: Reflects the acquisition of 881 shares acquired under the Company's ESPP. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 18:13 UTC |
LOUMEAU ERIC JChief Legal Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-049809 · doc4.xml · derivative · entry 4 LOUMEAU ERIC J · CIK 0001239648 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F6 · derivative.exercise_date: 50% of the total restricted stock units vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F6 · derivative.expiration_date: 50% of the total restricted stock units vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 18:13 UTC |
LOUMEAU ERIC JChief Legal Officer
|
SaleCommon Stock | 2,105 | $19.48 | $41,005.40 |
DisclosureSEC source: 0001209191-23-049809 · doc4.xml · nonDerivative · entry 2 LOUMEAU ERIC J · CIK 0001239648 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,777 F3 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 18:13 UTC |
LOUMEAU ERIC JChief Legal Officer
|
Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-049809 · doc4.xml · nonDerivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,882 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F2 · balance_after: Reflects the acquisition of 882 shares acquired under the Company's ESPP. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:12 UTC |
MULROY DENNISChief Financial Officer
|
Exercise / conversionRestricted Stock Unit · Derivative | 6,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-049808 · doc4.xml · derivative · entry 4 MULROY DENNIS · CIK 0001276840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,000 Underlying: Common Stock · 6,000 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: 50% of the total restricted stock units vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F5 · derivative.expiration_date: 50% of the total restricted stock units vest on September 14, 2023 and September 14, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:12 UTC |
MULROY DENNISChief Financial Officer
|
SaleCommon Stock | 2,105 | $19.48 | $41,005.40 |
DisclosureSEC source: 0001209191-23-049808 · doc4.xml · nonDerivative · entry 2 MULROY DENNIS · CIK 0001276840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,859 F2 · kind: The sale reported on this Form 4 represents shares sold by the Reporting Person to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction by the Reporting Person. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 22:12 UTC |
MULROY DENNISChief Financial Officer
|
Exercise / conversionCommon Stock | 6,000 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001209191-23-049808 · doc4.xml · nonDerivative · entry 1 MULROY DENNIS · CIK 0001276840 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,964 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. Read SEC document |
| April 03, 2023 Filed Apr 6, 2023 21:05 UTC |
Jain RitaDirector
|
GrantRestricted Stock Unit · Derivative | 3,234 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023604 · doc4.xml · derivative · entry 4 Jain Rita · CIK 0001707797 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,234 Underlying: Common Stock · 3,234 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F5 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F5 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| April 03, 2023 Filed Apr 6, 2023 21:05 UTC |
Jain RitaDirector
|
GrantRestricted Stock Unit · Derivative | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-023604 · doc4.xml · derivative · entry 3 Jain Rita · CIK 0001707797 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,900 Underlying: Common Stock · 3,900 shares Expires not disclosed F3 · derivative.exercise_price: Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F4 · derivative.exercise_date: The RSUs shall vest as to 1/3 of the total shares on June 15, 2024, and thereafter vests as to 1/3 of the total RSUs on June 15, 2025; and as to 1/3 of the total RSUs on June 15, 2026, subject to the provision of services to the Company on each vesting date. F4 · derivative.expiration_date: The RSUs shall vest as to 1/3 of the total shares on June 15, 2024, and thereafter vests as to 1/3 of the total RSUs on June 15, 2025; and as to 1/3 of the total RSUs on June 15, 2026, subject to the provision of services to the Company on each vesting date. Read SEC document |
| April 03, 2023 Filed Apr 6, 2023 21:05 UTC |
Jain RitaDirector
|
GrantStock Option (right to buy) · Derivative | 8,015 | $0.00 Strike: $22.09 | $0.00 |
DisclosureSEC source: 0001209191-23-023604 · doc4.xml · derivative · entry 2 Jain Rita · CIK 0001707797 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,015 Underlying: Common Stock · 8,015 shares Expires 2033-04-02 F2 · derivative.exercise_date: The stock option vests as of 1/9 of the total shares monthly beginning on May 6, 2023 and each month thereafter until fully vested on January 6, 2024, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| April 03, 2023 Filed Apr 6, 2023 21:05 UTC |
Jain RitaDirector
|
GrantStock Option (right to buy) · Derivative | 10,600 | $0.00 Strike: $22.09 | $0.00 |
DisclosureSEC source: 0001209191-23-023604 · doc4.xml · derivative · entry 1 Jain Rita · CIK 0001707797 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,600 Underlying: Common Stock · 10,600 shares Expires 2033-04-02 F1 · derivative.exercise_date: The stock option vests as of 1/36 of the total shares monthly beginning on May 6, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2023 Filed Jan 11, 2023 00:14 UTC |
Ware J. AnthonyDirector
|
GrantRestricted Stock Unit · Derivative | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002888 · doc4.xml · derivative · entry 2 Ware J. Anthony · CIK 0001715429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,900 Underlying: Common Stock · 3,900 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2023 Filed Jan 11, 2023 00:14 UTC |
Ware J. AnthonyDirector
|
GrantStock Option (right to buy) · Derivative | 10,600 | $0.00 Strike: $23.23 | $0.00 |
DisclosureSEC source: 0001209191-23-002888 · doc4.xml · derivative · entry 1 Ware J. Anthony · CIK 0001715429 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,600 Underlying: Common Stock · 10,600 shares Expires 2033-01-05 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2023 Filed Jan 11, 2023 00:07 UTC |
Lizzul Paul F.Chief Medical Officer
|
GrantRestricted Stock Unit · Derivative | 24,580 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002880 · doc4.xml · derivative · entry 2 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,580 Underlying: Common Stock · 24,580 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2023 Filed Jan 11, 2023 00:07 UTC |
Lizzul Paul F.Chief Medical Officer
|
GrantStock Option (right to buy) · Derivative | 67,070 | $0.00 Strike: $23.23 | $0.00 |
DisclosureSEC source: 0001209191-23-002880 · doc4.xml · derivative · entry 1 Lizzul Paul F. · CIK 0001711462 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,070 Underlying: Common Stock · 67,070 shares Expires 2033-01-05 F1 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 6, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2023 Filed Jan 11, 2023 00:04 UTC |
Faga DanielDirector · Interim CEO
|
GrantRestricted Stock Unit · Derivative | 71,400 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002877 · doc4.xml · derivative · entry 2 Faga Daniel · CIK 0001673528 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 71,400 Underlying: Common Stock · 71,400 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2023 Filed Jan 11, 2023 00:04 UTC |
Faga DanielDirector · Interim CEO
|
GrantStock Option (right to buy) · Derivative | 194,900 | $0.00 Strike: $23.23 | $0.00 |
DisclosureSEC source: 0001209191-23-002877 · doc4.xml · derivative · entry 1 Faga Daniel · CIK 0001673528 · Director · Interim CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 194,900 Underlying: Common Stock · 194,900 shares Expires 2033-01-05 F1 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 6, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2023 Filed Jan 11, 2023 00:11 UTC |
Schmid John P.Director
|
GrantRestricted Stock Unit · Derivative | 3,900 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002885 · doc4.xml · derivative · entry 2 Schmid John P. · CIK 0001478916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,900 Underlying: Common Stock · 3,900 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 100% of the total RSUs on the date of the Issuer's 2024 annual meeting of shareholders, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2023 Filed Jan 11, 2023 00:11 UTC |
Schmid John P.Director
|
GrantStock Option (right to buy) · Derivative | 10,600 | $0.00 Strike: $23.23 | $0.00 |
DisclosureSEC source: 0001209191-23-002885 · doc4.xml · derivative · entry 1 Schmid John P. · CIK 0001478916 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,600 Underlying: Common Stock · 10,600 shares Expires 2033-01-05 F1 · derivative.exercise_date: The stock option vests as to 1/12 of the total shares monthly commencing on February 6, 2023 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 19:08 UTC |
LOUMEAU ERIC JCOO, General Counsel
|
GrantRestricted Stock Unit · Derivative | 22,180 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-002881 · doc4.xml · derivative · entry 2 LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 22,180 Underlying: Common Stock · 22,180 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock award ("RSU") represents a contingent right to receive 1 share of the Issuer's Common Stock upon settlement for no consideration. F3 · derivative.exercise_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. F3 · derivative.expiration_date: The RSUs vests as to 25% of the total RSUs annually commencing on January 6, 2024 until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
| January 06, 2023 Filed Jan 10, 2023 19:08 UTC |
LOUMEAU ERIC JCOO, General Counsel
|
GrantStock Option (right to buy) · Derivative | 60,530 | $0.00 Strike: $23.23 | $0.00 |
DisclosureSEC source: 0001209191-23-002881 · doc4.xml · derivative · entry 1 LOUMEAU ERIC J · CIK 0001239648 · COO, General Counsel 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,530 Underlying: Common Stock · 60,530 shares Expires 2033-01-05 F1 · derivative.exercise_date: The stock option vests as to 25% of the total shares on January 6, 2024, and thereafter vests as to 1/48 of the total shares monthly until fully vested, subject to the Reporting Person's provision of service to the Issuer on each vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.